N-(4-tert-Butylphenyl)-5-[(4-fluoro-2-methoxyphenyl)-sulfamoyl]-1,3-dihydro-2H-isoindole-2-carboxamide

ID: ALA3605823

Chembl Id: CHEMBL3605823

PubChem CID: 102594368

Max Phase: Preclinical

Molecular Formula: C26H28FN3O4S

Molecular Weight: 497.59

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(F)ccc1NS(=O)(=O)c1ccc2c(c1)CN(C(=O)Nc1ccc(C(C)(C)C)cc1)C2

Standard InChI:  InChI=1S/C26H28FN3O4S/c1-26(2,3)19-6-9-21(10-7-19)28-25(31)30-15-17-5-11-22(13-18(17)16-30)35(32,33)29-23-12-8-20(27)14-24(23)34-4/h5-14,29H,15-16H2,1-4H3,(H,28,31)

Standard InChI Key:  BMKQGGFEZQEHAA-UHFFFAOYSA-N

Associated Targets(Human)

Liver microsome (8277 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MOGAT2 Tchem 2-acylglycerol O-acyltransferase 2 (219 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 497.59Molecular Weight (Monoisotopic): 497.1785AlogP: 5.48#Rotatable Bonds: 5
Polar Surface Area: 87.74Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 7.10CX Basic pKa: CX LogP: 4.82CX LogD: 4.43
Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.49Np Likeness Score: -1.96

References

1. Busujima T, Tanaka H, Shirasaki Y, Munetomo E, Saito M, Kitano K, Minagawa T, Yoshida K, Osaki N, Sato N..  (2015)  Identification of 2-[2-(4-tert-butylphenyl)ethyl]-N-(4-fluorophenyl)-1,2,3,4-tetrahydroisoquinoline-6-sulfonamide (29) as an orally available MGAT2 inhibitor.,  23  (17): [PMID:26210160] [10.1016/j.bmc.2015.06.065]
2.  (2015)  Nitrogen-containing condensed heterocyclic compound,